Gout News

Hmong patients with gout are on average 11 years younger, and demonstrate worse renal function, than non-Hmong patients with similar rates of comorbidities, according to data published in Arthritis Care & Research.

Patients with uncontrolled gout treated with pegloticase and mycophenolate mofetil exhibited reduced probability of developing antibodies to pegloticase and improved response rates at 12 weeks, according to data presented at ACR 2020.

Patients who have septic arthritis show significantly higher white blood cell count compared with patients who have gout, according to presented results.

At least 65% of rheumatologists at Veterans Affairs facilities view telemedicine as appropriate for established patients with gout, stable rheumatoid arthritis, osteoarthritis, stable spondyloarthritis and other diseases, researchers noted.

The percentage of adult arthritis visits to office-based physicians increased significantly during 2006-2015, with the percentage of visits where opioids were prescribed also increasing during that time, according to data.

Psoriatic arthritis and gout often present with similar symptoms and radiological signs, an overlap that may be more significant when these diseases occur concomitantly, noted a presenter at the 2020 Congress of Clinical Rheumatology-West.

An increased proportion of patients with uncontrolled gout maintained treatment response at 6 months with concomitant methotrexate and pegloticase, compared with pegloticase alone, according to data published in The Journal of Rheumatology.

New and emerging risk stratification tools can assist rheumatologists who are increasingly “taking on the challenge” of cardiovascular risk management in patients, according to a speaker at the 2020 Congress of Clinical Rheumatology-East.

While the 2020 American College of Rheumatology guidelines for gout management are a step up from the 2012 iteration, gaps remain in management of the disease, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

The burden of gout increased around the world from 1990 to 2017, with a total prevalent case count of 41.2 million, and 1.3 million years lived with disability, estimated for 2017, according to data published in Arthritis & Rheumatology.